###begin article-title 0
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Retinitis pigmentosa: mutation analysis of RHO, PRPF31, RP1, and IMPDH1 genes in patients from India
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
To screen for possible disease-causing mutations in rhodopsin (RHO), pre-mRNA processing factor 31 (PRPF31), retinitis pigmentosa 1 (RP1), and inosine monophosphate dehydrogenase 1 (IMPDH1) genes in Indian patients with isolated and autosomal dominant forms of retinitis pigmentosa (adRP). Information on such data is not available in India and hence this study was undertaken.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 106 113 <span type="species:ncbi:9606">patient</span>
Blood samples were obtained from 48 isolated and 53 adRP patients, who were recruited for the study. Each patient underwent a detailed clinical examination. Genomic DNA was extracted from the blood samples and screened for mutations in four genes using an ABI3100 Avant genetic analyzer. Reverse transcriptase polymerase chain reaction was performed to amplify the mutated (IVS6+1G/A) mRNA of PRPF31 in a two-generation adRP family.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 440 446 440 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 190 197 <span type="species:ncbi:9606">patient</span>
###xml 313 320 <span type="species:ncbi:9606">patient</span>
###xml 370 377 <span type="species:ncbi:9606">patient</span>
Of the 101 probands analyzed, three harbored possible disease-causing mutations. Pathogenic changes were observed in RHO and PRPF31. A RHO mutation, p.Gly106Arg, was found in an isolated RP patient with sectoral RP. Two novel, heterozygous mutations were identified in PRPF31: p.Lys120GlufsX122 in an isolated RP patient and a splice site mutation, IVS6+1G/A in an adRP patient. However, no disease-causing changes were observed in RP1 and IMPDH1.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 12 28 12 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO, PRPF31, RP1</italic>
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
We screened RHO, PRPF31, RP1, and IMPDH1 and identified causative mutations in 4% of isolated and 2% of adRP patients from India. To the best of our knowledge, this is the first report to identify frequencies of mutations in isolated and adRP patients in India.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 513 514 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 1257 1264 1257 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1424 1425 1424 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 879 887 <span type="species:ncbi:9606">patients</span>
Retinitis pigmentosa (RP) is a group of inherited retinal degenerative disorders characterized by progressive degeneration of the midperipheral retina, leading to night blindness, visual field constriction, and eventual loss of visual acuity. It is one of the leading causes of blindness in adults with an incidence of around 1 in 3,500 worldwide [1]. Clinical manifestations include pigment deposition in the retina and attenuation of retinal blood vessels followed by atrophy of the retinal pigment epithelium [2]. Electroretinogram (ERG) changes are present with abnormalities of both rod and cone ERGs, but rod ERGs are more affected than cone ERGs [3]. In advanced RP both rod and cone ERG responses are undetectable. RP can be inherited in an autosomal dominant (ad), recessive (ar), or x-linked (xl) manner, as well as in digenic, mitochondrial, or simplex patterns. Most patients with RP are isolated or sporadic with no known affected relatives, although some of these may have inheritances that are autosomal or X-linked recessive or dominant with incomplete penetrance. Despite having similar characteristics, there is a wide spectrum of clinical and genetic heterogeneity between the different modes of inheritance. RP involves nearly 37 genes (Table 1; ). However, this is only a partial representation of the total number of genes since it is believed that more than 60% of RP genes have yet to be identified [4].
###end p 11
###begin title 12
Number of retinitis pigmentosa genes and loci
###end title 12
###begin p 13
Tremendous research in the field of RP allowed the identification of nearly 47 genes. However, mutations in 37 genes are known to cause adRP and 10 adRP genes have been mapped but not identified yet ().
###end p 13
###begin p 14
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO)</italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 512 518 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 636 642 636 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
According to various reports, adRP represents between 15% and 35% of all RP cases. These values were derived from different studies, with the highest value being found in the United States [5] and the lowest in southern Europe [6]. However, accurate data on the frequency of RP in India is not available. To date, about 17 genes have been identified as causative of adRP. Rhodopsin (RHO) is the most frequently reported adRP gene, contributing to 20%-25% of cases [7], followed by pre-mRNA processing factor 31 (PRPF31) (2%-8% of adRP cases) [8,9], retinitis pigmentosa 1 (RP1) (5%-10%) [10], and inosine monophosphate dehydrogenase 1 (IMPDH1) (5%-10%) [11]. The frequency of mutations in these genes has been documented for many populations around the world, but not for patients from India.
###end p 14
###begin p 15
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
All of the aforenamed genes, excluding PRPF31, have been reported as disease-causing for arRP. IMPDH1 not only causes adRP but also Leber congenital amaurosis (LCA) [12]. Currently, treatment for RP is unavailable; however, animal models for a variety of retinal degenerations have been successfully rescued, using gene therapy approaches. Based on this success, it is anticipated that such treatments may become available for patients. Therefore, we undertook the first mutational analysis of four most frequently reported adRP genes in our patients.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 537 544 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 966 978 966 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO, PRPF31,</italic>
###xml 983 989 983 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 1051 1054 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 1092 1095 1092 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1229 1231 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1795 1798 1795 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1811 1817 1811 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 1830 1833 1830 1833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 1850 1856 1850 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 639 647 <span type="species:ncbi:9606">patients</span>
###xml 759 771 <span type="species:ncbi:9606">participants</span>
###xml 1752 1760 <span type="species:ncbi:9606">patients</span>
Study participants were selected after clinical examination (retina clinic) and pedigree analysis (genetic clinic) at Sankara Nethralaya. Clinical tests included Humphrey perimetry, fundus photography, and electroretinogram (ERG). A detailed pedigree was taken from the probands. Criteria for selecting adRP families were based on the occurrence of at least two affected generations with both sexes along with evidence of male to male transmission. The details of the patients and controls participated in the current study are given in Table 2. Genomic DNA was extracted from each 3 ml blood sample collected from 48 isolated and 53 adRP patients and 75 unrelated controls using standard phenol-chloroform methodology. Informed consent was obtained from all participants, and the research adhered to the tenets of Declaration of Helsinki and was approved by the hospital Internal Review Board. All the coding regions and the adjacent flanking intronic sequences of RHO, PRPF31, and IMPDH1 and the exons harboring previously reported mutations of the RP1 gene, namely exons 4F, 4G, and 4H of RP1 were amplified by polymerase chain reaction (PCR). The primers and the amplification conditions used were as reported previously [11,13-15]. PCR amplified products were electrophoresed at 100 v for 30 min on 2% ethidium bromide-agarose gels. The ethidium bromide-stained gels were captured by the gel documentation system ImageMasterR VDS (Amersham Pharmacia Biotech, Piscataway, NJ) using the Liscap software and analyzed using the Imagemaster Totallab gel documentation system. The PCR products were directly sequenced with ABI 3100 Avant Genetic Analyzer (Applied Biosystems, Foster City, CA) using the same oligomers employed in the PCR reactions. The patients' sequences were compared to known RHO (GenBank ), PRPF31 (GenBank ), RP1 (GenBank ), and IMPDH1 (GenBank ) sequences.
###end p 17
###begin title 18
###xml 15 27 <span type="species:ncbi:9606">participants</span>
Details of the participants in the study.
###end title 18
###begin p 19
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
###xml 248 260 <span type="species:ncbi:9606">participants</span>
Of 151 individuals recruited for the study, 101 were RP patients (48 isolated and 53 adRP) and 50 were unrelated healthy individuals. All the patients demonstrated typical features of RP. The average age has been calculated for all three groups of participants and is as tabulated above. However to overcome the problem of late onset of the disease in control group and to ensure the presence of the normal individuals in the same, we recruited individuals of age group between 42-70 years.
###end p 19
###begin title 20
Reverse transcriptase-polymerase chain reaction reactions
###end title 20
###begin p 21
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
RNA was isolated from 10 ml of heparinized blood samples, for each of the five members of an adRP family (family A) having the PRPF31 (IVS6+1G/A) mutation. RNA isolation was done using Trizol reagent (Sigma-Aldrich, St. Louis, MO), according to the manufacturer's instructions. Blood (10 ml) was collected from each individual. DNase-treated RNA, cloned MMLV reverse transcriptase (USB, Cleveland, OH) and random hexamers (Amersham Biosciences, Piscataway, NJ) were used to generate cDNA by reverse transcription-polymerase chain reaction (RT-PCR). The transcribed PRPF31 fragment from exon 3 to exon 8 was amplified using the following paired primers (forward, 5'-AAG TGA TGG GAC CAG TGG AG-3'; reverse, 5'-GTA GAC GAG AAG CCC GAC AG-3') and the conditions previously reported [16].The thermocycling profile was as follows: RT reaction (50 degreesC for 60 min, 80 degreesC for 2 min), followed by a three-step touchdown PCR (94 degreesC for 50 s; 65 degreesC for 1 min, drop 1 degreesC per cycle; 72 degreesC for 1 min) for 10 cycles, followed by a three-step PCR (94 degreesC for 50 s, 58 degreesC for 1 min, 72 degreesC for 1 min) for 24 cycles.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Disease-causing mutations were identified in three out of 101 unrelated RP patients screened. We observed a heterozygous p.Gly106Arg mutation in RHO as well as two heterozygous mutations in PRPF31: p.Lys120GlufsX122 and c.527+1G/A. None of these changes were found in 75 unrelated healthy controls.
###end p 23
###begin title 24
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
RHO screening
###end title 24
###begin title 25
p.Gly106Arg (c.316G/A)
###end title 25
###begin p 26
###xml 47 55 47 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 75 82 <span type="species:ncbi:9606">patient</span>
A missense change, p.Gly106Arg was identified (Figure 1) in an isolated RP patient (L2:50). However this change was not seen in any of the other family members or in 75 unrelated controls. Two intronic changes, c.232+4C/T and -26 A/G, were also detected in the study group.
###end p 26
###begin p 27
###xml 86 88 86 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 140 142 140 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 436 438 436 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 488 490 488 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</bold>
Clinical and molecular features of the proband (L2:50) with the p.Gly106Arg mutation. A: Pedigree showing the isolated form of the disease. B: Genomic DNA sequences (reverse) of a part of the RHO gene of L2:50 displaying the p.Gly106Arg mutation (top) and of a normal subject (bottom). The rectangular box shows the position of a heterozygous change at nucleotide 316 (c.316G/A, but the sequence shows the reverse sequence boxed as Y). C: Visual field test reveals a sectoral form of RP. D: Fundus (right eye) photograph showing mild retinitis pigmentosa changes.
###end p 27
###begin p 28
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+2</sup>
###xml 342 344 336 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 21 26 <span type="species:ncbi:9606">woman</span>
###xml 915 922 <span type="species:ncbi:9606">patient</span>
L2:50, a 44-year-old woman from southern India, had a two-year history of visual disability. She also had a history of night blindness for 11/2 years but had no history of night blindness in her family. Upon examination, her vision was 6/9; N6 in the right eye and 6/12+2; N6 in the left eye. Vision improved with - 0.50 DC X 90degrees to 6/6-1 and in the left eye -0.50 DS / - 0.50 DC X 120degrees to 6/6. Near vision was N6 with +1.50 DS. She was orthophoric; ocular movements were full, free, and painless. Slit-lamp examination revealed no abnormality except early posterior subcapsular cataract in both eyes. Intraocular pressure with applanation tonometry was 18 mmHg in the right eye and 17 mmHg in the left eye. Fundus examination with indirect ophthalmoscopy after full dilatation revealed a normal disc. There were sectoral lesions of bony corpuscles seen in the inferotemporal quadrant of both eyes .The patient was given the clinical diagnosis of bilateral sectoral RP. Humphrey visual field examination was done in both eyes. It showed superior constriction of the fields corresponding to inferior sectoral RP. ERG showed reduced rod and cone response in both eyes consistent with sectoral RP. None of the other family members were affected.
###end p 28
###begin title 29
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
PRPF31 screening
###end title 29
###begin p 30
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
We identified two novel pathogenic changes: 1) p.Lys120GlufsX122 (GenBank ) in an isolated RP case (N1:51); and 2) IVS6+1G/A (GenBank ) in an adRP family (family A). Five nonpathogenic intronic variations (Table 3) were also identified in the study group.
###end p 30
###begin title 31
Isocoding changes and polymorphisms identified.
###end title 31
###begin p 32
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO, PRPF31</italic>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
The polymorphisms identified in RHO, PRPF31, and RP1 were found in the noncoding or intronic regions. However, in IMPDH1, out of 5 polymorphisms, two were in the intronic region and the remaining three were in the exonic region (isocoding changes). Abbreviations: The " " symbol denotes isolated, the "*" denotes adRP and the "$" symbol denotes controls.
###end p 32
###begin title 33
p.Lys120GlufsX122 (c.358_359 del AA)
###end title 33
###begin p 34
###xml 59 67 59 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 119 126 <span type="species:ncbi:9606">patient</span>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
The deletion of two nucleotides AA at codon 120 in exon 5 (Figure 2) of PRPF31 leading to a frameshift was observed in patient N1:51. The truncated protein consisted of 122 amino acids with three novel amino acids before the stop codon. The patient, N1:51, could not be contacted, therefore detailed clinical examination of the proband and genetic analysis for the N1:51 family could not be performed.
###end p 34
###begin p 35
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 139 146 <span type="species:ncbi:9606">patient</span>
Electropherograms displaying a novel PRPF31 mutation, p.Lys120GlufsX122. Genomic DNA sequences (reverse primer) of a part of PRPF31 from a patient with the p.Lys120GlufsX122 mutation (top) and from a normal subject (bottom). The rectangular box shows the position of a heterozygous deletion of two nucleotides at codon 120 (c. c.358_359 del AA, but the sequence shows the reverse sequence boxed as TT).
###end p 35
###begin title 36
IVS6+1G/A (c.358_359del AA)
###end title 36
###begin p 37
###xml 169 177 169 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 609 615 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 764 772 764 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 1110 1118 1110 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 51 56 <span type="species:ncbi:9606">child</span>
###xml 417 422 <span type="species:ncbi:9606">child</span>
The proband with this splice site mutation was the child of an affected mother and unaffected father. Upon further analysis of genomic DNA of other members of family A (Figure 3), we found the mutation in affected members, I-1 and II-1, and a clinically normal individual, II- 2, but not in other two clinically normal individuals, I-2 and II-3. Individual II-2 may not have manifestation for two reasons: either the child was too young (3.5 years) to manifest the disease, or there was incomplete penetrance. To test whether the splice-site mutation leads to a defective mRNA, we performed RT-PCR to amplify PRPF31 cDNA from total RNA isolated from peripheral blood obtained from all members of family A. A fragment of about 559 bp was obtained, and, as shown in Figure 4, the cDNA sequencing revealed intron 6 retention in two affected members (I-1, II-1) and an asymptomatic individual (II-2). The transversion G/A occurred in the first nucleotide of intron 6, interrupting its splicing and leading to a frameshift and truncated protein of 186 amino acids with 11 novel amino acids before a premature stop. Figure 5 shows fundus photographs documenting four members of family A. The youngest sibling (II-3) underwent an indirect ophthalmoscopic examination and was found to have a normal fundus. However other tests; field of vision, fundus fluorescence angiography and ERG could not be performed in individual II-3 due to very young age.
###end p 37
###begin p 38
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31.</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Pedigree of family A harboring a IVS6+1G/A mutation in PRPF31. The change in the genomic DNA sequence was observed in two affected patients and an asymptomatic individual. Normal individuals are shown as clear circles (females) or squares (males), and affected individuals are shown as solid symbols. The clear square with the symbol "?" indicates an asymptomatic carrier.
###end p 38
###begin p 39
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
Electropherograms displaying intron 6 retention. A comparison of a portion of PRPF31 cDNA sequences between the unaffected (top: I-2) and the affected (bottom: II- 1) revealed intron 6 retention in all affected and asymptomatic individuals of family A. The green hatched box represents exonic region, and the red rectangular box indicates the start position of intron 6 retention (non-hatched) in the proband.
###end p 39
###begin p 40
Fundus images of I-1, I-2, II-1, and II-2 of family A. The fundus pictures from unaffected members I-2 and II-2 were normal. However, typical features of retinitis pigmentosa could be well appreciated in affected members I-1 and II-1.The other details of the members of family A are as follows; Individual I-1 was a 24-year-old female with a history of night blindness since 8 years. Her visual acuity was counting fingers at 4 meters, and was not improving with glasses (NIG). Fundus examination revealed arteriolar attenuation, bony spicules with degenerative macular changes, and disc pallor. The electroretinogram (ERG) was nonrecordable, fields were grossly defective. Individual, I-2 was a 32-year-old male with a vision of 6/6 and normal fundus. Individual II-1 (proband) was a 5-year-old female with a complaint of night blindness since 6 months. Fundus revealed attenuated vessels, normal disc, dull foveal reflex, and altered retinal sheen. The ERG was nonrecordable in both the eyes. Individuals II-2 was a 3.5-year-old male with normal vision and fundus. Individual II-3 is a 2-year-old female with normal fundus. The ERG and visual field test could not be done due to pediatric age.
###end p 40
###begin title 41
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
RP1 and IMPDH1 screening
###end title 41
###begin p 42
###xml 43 50 43 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
Except for a few nonpathogenic variations (Table 3), no other variations were observed in RP1 and IMPDH1. All intronic polymorphisms encountered in this study were analyzed using  prediction software. It was found that none of these changes were likely to alter RNA splicing.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 20 37 20 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO, PRPF31, RP1,</italic>
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
In our screening of RHO, PRPF31, RP1, and IMPDH1 genes in 101 index patients, we identified three pathogenic changes: one in RHO and two in PRPF31. In the United States, the United Kingdom, and Europe, RHO mutations account for 20%-25% of all adRP cases [7]. So far, only limited research has been performed in India on the genetics of RP hence such data was not available.
###end p 44
###begin p 45
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 906 909 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 1132 1139 <span type="species:ncbi:9606">patient</span>
Prior to this study, only two RP-related studies have been reported using families from India [17,18]. However these studies did not report the frequency rate of RHO mutations in isolated/adRP patients.  et al. [17] identified an RHO mutation in a family with arRP, whereas Dikshit et al. [18] mainly focused on the mutations reported in codons 345 and 347. In the latter study, the whole gene was not screened and 100 Indian RP patients were recruited from 76 families, irrespective of the inheritance of RP [18]. However, in the present study, a p.Gly106Arg mutation was detected in approximately 2% of isolated RP cases thus suggesting low frequency of RHO mutations in the Indian population. The observed low frequency of RHO mutations in the current study could be due to ethnic variation or small sample size. However since single gross deletions have also been encountered at a frequency of 0.8% in RHO, the direct sequencing based method in the current study would have failed to detect this type of mutation. Another finding is that, similar to previous reports, the same missense mutation was identified in an isolated RP patient, who clinically displayed the sectoral form of RP [19,20].
###end p 45
###begin p 46
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 1327 1335 1327 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 292 299 <span type="species:ncbi:9606">patient</span>
Two novel disease-causing changes were identified in PRPF31. Although our sample included patients from all over India, PRPF31 mutations were identified only in the patients from the northern region of the country. The frameshift mutation, p.Lys120GlufsX122, was identified in an isolated RP patient. However, as the proband was not available for further analysis, we could not assess the penetrance status of the disease in the family. The second novel mutation identified was a splice site mutation, IVS6+1G/A. Upon further genetic analysis of other family members of the proband with IVS6+1G/A, we found the mutation in clinically affected as well as in a clinically normal individual, suggesting incomplete penetrance of the disease in this pedigree. Normally the process of splicing occurs at the first nucleotide of an intron that removes the noncoding region. However, in this case splicing at the first nucleotide of intron 6 was skipped due to the transversion of G/A, thus resulting in the retention of intron 6. Intron retention was confirmed by sequencing cDNA derived from lymphocyte RNA. The introduction of novel nucleotides in the coding region altered the open reading frame, resulting in the premature termination of the protein with a total of 186 amino acids instead of in the wild-type of 499 amino acids (Figure 6); this change was a novel finding.
###end p 46
###begin p 47
Alignment of protein sequences of the PRPF31 protein The wild-type sequence and two identified novel mutants, IVS6+1G/A and p.Lys120GlufsX122, are shown. Both the mutations resulted in a premature truncation of the protein.
###end p 47
###begin p 48
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 201 208 <span type="species:ncbi:9606">patient</span>
The contribution of the PRPF31 mutations in our population was determined to be 2% in isolated cases and 2% in adRP cases. The percentage would increase to 4% in adRP, considering that the isolated RP patient with p.Lys120GlufsX122 could be an adRP case showing incomplete penetrance. In such a case, the frequency of PRPF31 mutations in adRP was found to be approximately equal to that reported in the United Kingdom (5%) [21], but it is more than what has been reported in Spain (2%) [22], and Japan (2%) [23]. However, the frequency of these mutations are relatively low when compared to reports from the United States (8%) [9]. This could be due to the presence of large deletions, insertions, or genomic rearrangements, which could not be detected by the current techniques employed in this study.
###end p 48
###begin p 49
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
The two novel mutations identified in this study result in the production of protein devoid of nuclear localization signal (NLS; Figure 7). NLS is located between residue 351-364, and it is critical for the export of PRPF31 protein from the cytoplasm to nucleus. Since NLS is absent in both the mutant proteins, the translocation of the protein from the cytoplasm into the nucleus is hindered, affecting its spicing function [24]. Thus, these mutations seem to induce a pathogenic mechanism by haploinsufficiency rather than by a dominant negative effect.
###end p 49
###begin p 50
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 141 146 <span type="species:ncbi:9606">human</span>
Schematic representation of PRPF31 and its protein structure. Illustrated are positions of reported mutations (including large deletions) in human PRPF31 and domain features of predicted PRPF31 protein. Two novel PRPF31 mutations reported in this study are depicted in bold. Distance between exons and domains are not drawn to scale.
###end p 50
###begin p 51
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 406 412 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 453 459 453 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
RP1 screening revealed a previously reported polymorphism, p.Arg 872 His. Pathogenic changes were not identified, due to partial screening of the gene. In this study, we screened only a segment of RP1 comprising of exons 4F, 4G, and 4H because of the occurrence of frequently reported mutations, p.Arg677X, p.Gln679X, and two other deletions at codon 765 and 763 in this region. Disease-causing changes in IMPDH1 were not identified, which implies that IMPDH1 mutations may not be a causative of adRP in our population.
###end p 51
###begin p 52
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 319 325 319 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1</italic>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP1,</italic>
###xml 545 551 545 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1</italic>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
In summary, we identified three pathogenic changes: p.Gly106Arg in RHO, and two novel mutations, p.Lys120GlufsX122 and IVS6+1G/A in PRPF31. Causative mutations were identified in approximately 3% of our study group. The relative contribution of each gene to the total number of mutations was estimated as 1% RHO and 4% PRPF31. However, we did not identify causative mutations in RP1 and IMPDH1 .To the best of our knowledge, this is the first study undertaken to determine the contribution of commonly reported adRP genes, RHO, PRPF31, RP1, and IMPDH1 in RP patients from India.
###end p 52
###begin title 53
Acknowledgments
###end title 53
###begin p 54
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
We thank the patients and their families for taking part in the study. We also thank Aung Tin and Eranga N. Vithana, Singapore National Eye Centre, Singapore, for providing PRPF31 primers. We thank Ms. Ciara Odriscoll, Institute of Ophthalmology, University College London, UK, for language correction of this manuscript. This study was supported by a grant from the Indian Council of Medical Research (Ref No: 5/4/6/4/2001-NCD-II), New Delhi, India and NIHR Biomedical Research Centre for Ophthalmology, UK.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
Retinitis pigmentosa: genes, proteins and prospects.
###end article-title 56
###begin article-title 57
Retinal photoreceptor dystrophies.
###end article-title 57
###begin article-title 58
Gene mutations in retinitis pigmentosa and their clinical implications.
###end article-title 58
###begin article-title 59
Prevalence of retinitis pigmentosa in Maine.
###end article-title 59
###begin article-title 60
Retinitis pigmentosa in Spain. The Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa.
###end article-title 60
###begin article-title 61
Retinitis pigmentosa: defined from a molecular point of view.
###end article-title 61
###begin article-title 62
Mutation c. 1142 del G in the PRPF31 gene in a family with autosomal dominant retinitis pigmentosa (RP11) and its implications.
###end article-title 62
###begin article-title 63
Prevalence of disease causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
###end article-title 63
###begin article-title 64
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
###end article-title 64
###begin article-title 65
Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa.
###end article-title 65
###begin article-title 66
Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis.
###end article-title 66
###begin article-title 67
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
Human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).
###end article-title 68
###begin article-title 69
Mutations in the RP1 gene causing autosomal dominant retinitis pigmentosa.
###end article-title 69
###begin article-title 70
A novel PRPF31 splice-site mutation in a Chinese family with autosomal dominant retinitis pigmentosa.
###end article-title 70
###begin article-title 71
Missense rhodopsin mutation in a family with recessive RP.
###end article-title 71
###begin article-title 72
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Mutation analysis of codons 345 and 347 of rhodopsin gene in Indian retinitis pigmentosa patients.
###end article-title 72
###begin article-title 73
Ocular findings associated with a rhodopsin gene codon 106 mutation. Glycine-to-arginine change in autosomal dominant retinitis pigmentosa.
###end article-title 73
###begin article-title 74
Rhodopsin gene codon 106 mutation (Gly-to-Arg) in a Japanese family with autosomal dominant retinitis pigmentosa.
###end article-title 74
###begin article-title 75
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
###end article-title 75
###begin article-title 76
Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa.
###end article-title 76
###begin article-title 77
Mutation c. 1142 del G in the PRPF31 gene in a family with autosomal dominant retinitis pigmentosa (RP11) and its implications.
###end article-title 77
###begin article-title 78
Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31.
###end article-title 78

